Management of Rheumatoid Arthritis associated ILD

Speciality: Rheumatology

Description:

A warm welcome to all the medical professionals in this interesting session on RA-associated ILD: Multidisciplinary care, immunosuppression, pulmonary rehab optimize outcomes. 

The management of Rheumatoid Arthritis (RA) associated Interstitial Lung Disease (ILD) involves a multidisciplinary approach aimed at reducing inflammation, preserving lung function, and improving quality of life. Treatment typically includes immunosuppressive therapy, such as disease-modifying antirheumatic drugs (DMARDs) and corticosteroids, to control RA activity and prevent further lung damage.

Pulmonary rehabilitation programs help optimize respiratory function and physical conditioning. Close monitoring through pulmonary function tests (PFTs) and imaging studies is essential to assess disease progression and response to treatment. Additionally, patient education on symptom recognition, medication adherence, and lifestyle modifications is crucial for long-term management.

In severe cases, advanced therapies like biologic agents may be considered. Overall, a comprehensive management strategy involving collaboration between rheumatologists, pulmonologists, and other healthcare professionals is essential to effectively address RA-associated ILD and improve patient outcomes.

Therefore, get an overall knowledge on RA-associated ILD: Multidisciplinary care, immunosuppression, pulmonary rehab optimize outcomes. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.

See More Webinars @ Hidoc Webinars